Hair Cannabinoids and Hippocampal Volume Supplied an Association Rather Than a Protection Trial

A small imaging study summarized in the historical review linked hair cannabinoid measurements with hippocampal volume. It did not experimentally establish that CBD protected brain structure from THC.

The comparison combined imaging and hair analysis

The review describes Demirakca and colleagues’ study of 11 chronic recreational cannabis users and 13 healthy controls. The users had lower gray-matter volume in the right anterior hippocampus. Higher THC and lower CBD measurements in hair were associated with the volume finding. These were observational comparisons rather than assigned cannabinoid treatments.

The specimen and endpoint have different meanings

Hair measurements characterize cannabinoids detected in a particular specimen, while imaging estimates a structural feature. Neither directly measures THC concentration in the hippocampus at the time of scanning. The association also does not establish the timing of a structural change or show that a particular constituent caused it.

Several explanations remain possible

Cannabis-use history, product selection and other participant characteristics can vary together. The review notes broader inconsistencies among structural studies related to exposure patterns and composition. A stronger causal protection claim would require evidence beyond a correlation between hair constituents and anatomy. The appropriate account retains the small groups, regional finding and observational design. It does not establish permanent injury, a safe ratio or an individual diagnosis from a hair result.

Related analysis: the broader evidence and its limitations.

Research cited

This analysis uses the supplied review; individual experiments are discussed as summarized there: Niesink and van Laar (2013). Does cannabidiol protect against adverse psychological effects of THC?

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Adding CBD in a Small MS Cannabis-Extract Trial Was Associated With More Adverse Events

A small MS trial summarized in the early human CBD review reported more adverse events with a CBD-containing cannabis extract than with THC alone. The combination did not demonstrate a general safety advantage. The study had a defined clinical comparison The review describes a four-week crossover study involving 16 patients…

Spread the love

Read Article: Adding CBD in a Small MS Cannabis-Extract Trial Was Associated With More Adverse Events

A Cancer-Anorexia Cannabis Trial Stopped at Interim Analysis for Lack of Group Differences

A cancer-related anorexia trial summarized in the early human CBD review was terminated at interim analysis because the study arms did not differ. Its combination treatment did not supply positive appetite-treatment evidence in that comparison. The trial compared more than one active preparation The review describes 243 patients assigned to…

Spread the love

Read Article: A Cancer-Anorexia Cannabis Trial Stopped at Interim Analysis for Lack of Group Differences

A CBD–Nabilone Experiment Reported Only Marginal Changes in Intoxication and Depth Perception

A small historical crossover experiment summarized in the human CBD review reported marginal reductions in nabilone-related intoxication and binocular depth-perception impairment. It did not establish broad protection against synthetic-cannabinoid effects. The comparison involved a specific synthetic cannabinoid Nine male participants received oral CBD at 200 mg, alone and with nabilone…

Spread the love

Read Article: A CBD–Nabilone Experiment Reported Only Marginal Changes in Intoxication and Depth Perception

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us